栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 2,003 | 2,023 | 1,988 | 2,007 | -18 | -0.9% | 94,400 |
| 2024/04/25 | 2,022 | 2,037 | 2,004 | 2,025 | +20 | +1% | 147,600 |
| 2024/04/24 | 2,000 | 2,015 | 1,997 | 2,005 | -1 | ±0% | 45,500 |
| 2024/04/23 | 2,000 | 2,016 | 1,979 | 2,006 | +47 | +2.4% | 116,900 |
| 2024/04/22 | 1,952 | 1,968 | 1,947 | 1,959 | +24 | +1.2% | 53,200 |
| 2024/04/19 | 1,951 | 1,964 | 1,908 | 1,935 | -35 | -1.8% | 130,500 |
| 2024/04/18 | 1,955 | 1,975 | 1,945 | 1,970 | +15 | +0.8% | 79,500 |
| 2024/04/17 | 2,000 | 2,003 | 1,945 | 1,955 | -41 | -2.1% | 118,900 |
| 2024/04/16 | 1,965 | 2,008 | 1,950 | 1,996 | -4 | -0.2% | 94,500 |
| 2024/04/15 | 1,985 | 2,009 | 1,976 | 2,000 | +1 | +0.1% | 72,400 |
| 2024/04/12 | 2,034 | 2,049 | 1,999 | 1,999 | -23 | -1.1% | 129,400 |
| 2024/04/11 | 2,001 | 2,034 | 1,999 | 2,022 | +1 | ±0% | 94,400 |
| 2024/04/10 | 2,008 | 2,036 | 2,005 | 2,021 | +14 | +0.7% | 98,900 |
| 2024/04/09 | 1,998 | 2,015 | 1,996 | 2,007 | +10 | +0.5% | 73,400 |
| 2024/04/08 | 1,970 | 2,008 | 1,970 | 1,997 | +37 | +1.9% | 157,100 |
| 2024/04/05 | 1,956 | 1,977 | 1,931 | 1,960 | +10 | +0.5% | 152,200 |
| 2024/04/04 | 1,962 | 1,971 | 1,942 | 1,950 | -1 | -0.1% | 124,900 |
| 2024/04/03 | 1,973 | 1,981 | 1,941 | 1,951 | -29 | -1.5% | 189,900 |
| 2024/04/02 | 1,983 | 1,983 | 1,972 | 1,980 | -4 | -0.2% | 79,700 |
| 2024/04/01 | 2,012 | 2,012 | 1,957 | 1,984 | -16 | -0.8% | 89,500 |
| 2024/03/29 | 1,954 | 2,006 | 1,954 | 2,000 | +35 | +1.8% | 71,000 |
| 2024/03/28 | 1,990 | 2,011 | 1,954 | 1,965 | -48 | -2.4% | 257,000 |
| 2024/03/27 | 2,022 | 2,026 | 1,997 | 2,013 | +42 | +2.1% | 170,000 |
| 2024/03/26 | 1,948 | 1,978 | 1,948 | 1,971 | +13 | +0.7% | 86,900 |
| 2024/03/25 | 1,978 | 1,981 | 1,949 | 1,958 | -36 | -1.8% | 95,500 |
| 2024/03/22 | 1,967 | 2,006 | 1,967 | 1,994 | +27 | +1.4% | 130,500 |
| 2024/03/21 | 1,973 | 1,980 | 1,924 | 1,967 | +6 | +0.3% | 254,000 |
| 2024/03/19 | 1,937 | 1,982 | 1,921 | 1,961 | +29 | +1.5% | 219,500 |
| 2024/03/18 | 1,919 | 1,939 | 1,912 | 1,932 | +32 | +1.7% | 129,500 |
| 2024/03/15 | 1,931 | 1,931 | 1,885 | 1,900 | -31 | -1.6% | 258,100 |
| 2024/03/14 | 1,982 | 1,982 | 1,914 | 1,931 | -51 | -2.6% | 200,200 |
| 2024/03/13 | 2,018 | 2,029 | 1,948 | 1,982 | -30 | -1.5% | 158,600 |
| 2024/03/12 | 1,986 | 2,021 | 1,963 | 2,012 | +2 | +0.1% | 280,200 |
| 2024/03/11 | 1,880 | 2,055 | 1,874 | 2,010 | +105 | +5.5% | 766,800 |
| 2024/03/08 | 1,900 | 1,921 | 1,891 | 1,905 | -4 | -0.2% | 179,400 |
| 2024/03/07 | 1,903 | 1,926 | 1,902 | 1,909 | +9 | +0.5% | 132,500 |
| 2024/03/06 | 1,900 | 1,921 | 1,889 | 1,900 | +8 | +0.4% | 134,700 |
| 2024/03/05 | 1,889 | 1,905 | 1,879 | 1,892 | -7 | -0.4% | 329,300 |
| 2024/03/04 | 1,905 | 1,944 | 1,890 | 1,899 | -1 | -0.1% | 223,400 |
| 2024/03/01 | 1,870 | 1,906 | 1,851 | 1,900 | +12 | +0.6% | 351,200 |
| 2024/02/29 | 1,880 | 1,898 | 1,871 | 1,888 | +8 | +0.4% | 142,200 |
| 2024/02/28 | 1,889 | 1,931 | 1,879 | 1,880 | +4 | +0.2% | 146,400 |
| 2024/02/27 | 1,856 | 1,890 | 1,852 | 1,876 | +20 | +1.1% | 153,200 |
| 2024/02/26 | 1,878 | 1,895 | 1,850 | 1,856 | -7 | -0.4% | 107,500 |
| 2024/02/22 | 1,868 | 1,869 | 1,838 | 1,863 | -14 | -0.7% | 130,800 |
| 2024/02/21 | 1,889 | 1,902 | 1,860 | 1,877 | +3 | +0.2% | 98,700 |
| 2024/02/20 | 1,896 | 1,898 | 1,873 | 1,874 | -22 | -1.2% | 142,400 |
| 2024/02/19 | 1,911 | 1,918 | 1,883 | 1,896 | -15 | -0.8% | 88,700 |
| 2024/02/16 | 1,935 | 1,935 | 1,906 | 1,911 | +3 | +0.2% | 133,300 |
| 2024/02/15 | 1,959 | 1,964 | 1,902 | 1,908 | -32 | -1.6% | 140,400 |
1～
50
件表示中 / 6699件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 200,700円 | -6.4% | -45.4% | 2.54% | 22.84倍 | 1.39倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| ゼリア新薬 | 205,900円 | +6.8% | +18.7% | 2.14% | 12.97倍 | 1.20倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 79,700円 | +32.2% | +84.6% | 2.51% | 13.63倍 | 1.77倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 226,000円 | +2.6% | +5.1% | 1.77% | 10.33倍 | 1.09倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 73,700円 | +7.9% | -26.7% | 3.53% | 15.47倍 | 0.56倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
